FDA Ok’s New Medical Device To Treat ADHD In Children And Teens

Stock Image.

WESTERN NEW YORK – A medical device to treat childhood Attention Deficit Hyperactivity Disorder (ADAD) has been approved by the U.S. Food and Drug Administration (FDA).

It’s the first medical device of its kind. The Monarch External Trigeminal Nerve Stimulation System was given the ‘okay’ by the FDA on Friday.

It’s designated for children ages seven to 12 who are not currently on medication for the disorder; and is designed to be worn while a child is sleeping.

A small adhesive patch is placed on the child’s forehead and the pocket-sized delivers a low-level electrical pulse to the parts of the brain responsible for ADAD symptoms.

The device has also been investigated as a possible treatment for traumatic brain injury in veterans.

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.


Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.